Skip to main content

Table 1 Demographic, clinical, and laboratory information of patients

From: Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients

Subject Sex Age (years) Medications CRP (mg/l) ESR (mm/hour)
RA Patients      
   RA-1aa Male 65 None 4.14b 9
   RA-1b Male 65 MTX 11.8 18
   RA-2 Female 33 Etanercept, naproxen 25.7 18
   RA-3 Female 43 Etanercept No data No data
   RA-4 Female 45 None 98.4 84
   RA-5 Female 55 MTX 4.8 26
   RA-6 Female 73 None 2.1 30
   RA-7 Female 51 Hydroxychloroquine, MTX, prednisone No data 15
   RA-8 Male 61 Prednisone, MTX, hydroxychloroquine, sulfasalazine No data 1
   RA-9 Male 46 Methylprednisolone, MTX, etanercept 2 9
   RA-10 Female 32 Leflunomide 94.2 63
   RA-11 Female 50 Etanercept, MTX No data No data
   RA-12 Male 67 MTX, celecoxib, prednisone 0.6 11
   RA-13 Female 55 MTX No data 17
   RA-14 Female 33 Hydroxychloroquine, ibuprofen 2.8 7
   RA-15 Female 55 None 168.2 88
   RA-16 Female 56 Prednisone, minocycline No data No data
Disease control individuals      
   SLE1 Female 36 Hydroxychloroquine, prednisone, mycophenolate mofetil   
   SjS1 Female 30 Hydroxychloroquine, mycophenolate mofetil   
   SjS2 Male 21 Hydroxychloroquine   
   SSc1 Female 57 Cyclosporine, hydroxychloroquine, prednisone, mycophenolate mofetil   
  1. aSample collected from RA-1 before and after MTX treatment. bNormal value less than 0.8. The normal CRP is <4.9 mg/l, and the normal ESR is <20 mm/hour for females and <10 mm/hour for males. CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; MTX, methotrexate; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SjS, Sjögren's syndrome; SSc, scleroderma.